Tilray Brands, Inc. (TLRY)
Tilray Brands Is A Buy Again
Upgrading Tilray Brands to Buy due to improved valuation, net cash position, and technical support near recent lows, despite ongoing volatility and sector headwinds. Q4 results showed mixed performance: revenue missed expectations but adjusted EBITDA beat; cannabis margins improved, though overall growth remains challenging. Valuation is attractive, trading below tangible book value and at under 10x FY26 projected adjusted EBITDA, limiting downside risk versus peers.
Should You Buy, Hold or Sell TLRY Stock Post Q4 Earnings Release?
Tilray posts record non-cannabis revenues in fiscal 2025, but Q4 sales slip as cannabis weakness pressures overall results.
Tilray Brands Reports In-Line Q4-2025 And FY2025 Results Amidst Weakening Sector
Tilray Brands posted sequential revenue growth but showed a decrease YoY. The company reported a high net loss due to non-cash impairments. Tilray Brands expects 2026 to be better than 2025, but uncertainty and risk remain.
Tilray Brands, Inc. (TLRY) Q4 2025 Earnings Call Transcript
Tilray Brands, Inc. (NASDAQ:TLRY ) Q4 2025 Earnings Conference Call July 28, 2025 4:30 PM ET Company Participants Berrin Noorata - Chief Corporate Affairs Officer Carl A. Merton - CFO & Principal Accounting Officer Denise Menikheim Faltischek - Chief Strategy Officer & Head of International Irwin David Simon - President, CEO & Chairman Rajnish Ohri - Corporate Participant Conference Call Participants Aaron Thomas Grey - Alliance Global Partners, Research Division Frederico Yokota Choucair Gomes - ATB Capital Markets Inc., Research Division Kaumil S.
Tilray Q4 Results Show Major Problems
Tilray's fiscal Q4 results disappointed, with revenues missing estimates and a massive $1.26 billion net loss driven by impairment charges. TLRY's ongoing cash burn has resulted in tremendous shareholder dilution to keep the balance sheet from weakening further. A reverse stock split is likely coming to maintain exchange listing requirements, which typically pressures share prices further.
Tilray Brands, Inc. (TLRY) Q4 Earnings Beat Estimates
Tilray Brands, Inc. (TLRY) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.03 per share. This compares to a loss of $0.04 per share a year ago.
Tilray Brands, Inc. (TLRY) Stock Slides as Market Rises: Facts to Know Before You Trade
Tilray Brands, Inc. (TLRY) closed at $0.74 in the latest trading session, marking a -6.34% move from the prior day.
Exploring Analyst Estimates for Tilray Brands (TLRY) Q4 Earnings, Beyond Revenue and EPS
Besides Wall Street's top-and-bottom-line estimates for Tilray Brands (TLRY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended May 2025.
Tilray Brands, Inc. (TLRY) Beats Stock Market Upswing: What Investors Need to Know
In the latest trading session, Tilray Brands, Inc. (TLRY) closed at $0.61, marking a +1.21% move from the previous day.
Tilray Shares Blazing: What's Behind the 55% Rally This Month?
Tilray Brands Inc. NASDAQ: TLRY, once a leading light in the legal cannabis industry with shares trading as high as nearly $150, has seen its stock price almost entirely collapse in recent years. A multitude of factors may be to blame—the lack of federal legalization of recreational cannabis, regulatory inconsistencies, problems matching supply and demand, and more have all devastated the industry.
Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors
In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $0.58, denoting a -8.88% move from the preceding trading day.
Tilray Brands: Gambling A Little Money Now Could Generate Sizable Future Payoff
Tilray Brands is a high-risk, high-reward opportunity after a 99%+ decline over seven years, now trading at deep value levels with minimal bankruptcy risk. The company is nearing profitability, with projected positive cash flow in 2025-26, marking a significant turnaround from years of losses. Potential U.S. regulatory changes under President Trump could dramatically boost industry sentiment and Tilray's prospects.
